|
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
RECRUITINGPhase 2Sponsored by Alto Neuroscience
Actively Recruiting
PhasePhase 2
SponsorAlto Neuroscience
Started2026-05-20
Est. completion2027-11
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations53 sites
View on ClinicalTrials.gov →
NCT07553637
Summary
The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: * Male and female participants, ages 18 to 75 years, inclusive, at the time of signing the ICF. * Prior diagnosis of MDD without psychotic symptoms (in the current episode) and have confirmatory diagnosis of current MDD (moderate to severe). * Failure to respond (\<50% improvement) to at least 2-5 antidepressant treatments (including the current treatment) * Currently taking a stable dose of at least 1 but no more than 2 oral antidepressants at baseline Exclusion Criteria: * Evidence of unstable medical condition * Concurrent use of any prohibited medications or substance use disorder * Diagnosed bipolar disorder or a psychotic disorder or symptoms * Significant current PTSD symptoms or history of PTSD * Clinically significant current impulse control difficulties * Has a history of hypersensitivity or allergic reaction to ALTO-207 or any of its components/excipients * Concurrent or recent participation in another clinical trial for mental illness involving an investigational product or device
Conditions2
DepressionTreatment Resistant Depression (TRD)
Interventions1
Locations53 sites
Site 7173
Site 7153
Site 7195
Site 7069
Find trials near these locations
Depression trials in PhoenixDepression trials in Los AngelesDepression trials in SacramentoDepression trials in San DiegoDepression trials in San JoseDepression trials in IndianapolisDepression trials in BaltimoreDepression trials in CharlotteDepression trials in AustinDepression trials in DallasDepression trials in Fort WorthDepression trials in HoustonAll trials in AlabamaAll trials in ArizonaAll trials in CaliforniaAll trials in ConnecticutAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in IndianaAll trials in MarylandAll trials in MassachusettsAll trials in MichiganAll trials in MissouriAll trials in New JerseyAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in Rhode IslandAll trials in South CarolinaAll trials in TexasAll trials in VirginiaAll trials in WashingtonAll trials in West Virginia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorAlto Neuroscience
Started2026-05-20
Est. completion2027-11
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
Locations53 sites
View on ClinicalTrials.gov →
NCT07553637